Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Timothy E. Albertson, James A. Chenoweth, Skyler J. Pearson & Susan Murin. (2020) The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS). Expert Opinion on Pharmacotherapy 21:2, pages 213-231.
Read now
Read now
Coralie Barrera, Steffi Rocchi, Bruno Degano, Thibaud Soumagne, Lucie Laurent, Anne-Pauline Bellanger, Jean-Jacques Laplante, Laurence Millon, Jean-Charles Dalphin & Gabriel Reboux. (2019) Microbial exposure to dairy farmers’ dwellings and COPD occurrence. International Journal of Environmental Health Research 29:4, pages 387-399.
Read now
Read now
Xiaoli Zhang, Yuqing Chen, Liyu Fan, Jiaqi Ye, Junsheng Fan, Xinjie Xu, Danming You, Sihan Liu, Xin Chen & Peng Luo. (2018) Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap. Drug Design, Development and Therapy 12, pages 2371-2379.
Read now
Read now
Neil C Thomson. (2018) Challenges in the management of asthma associated with smoking-induced airway diseases. Expert Opinion on Pharmacotherapy 19:14, pages 1565-1579.
Read now
Read now
Yang Xia, Wen Li & Huahao Shen. (2017) Anti-IgE therapy as novel target for asthma-COPD overlap syndrome: More questions before celebration. Journal of Asthma 54:2, pages 113-113.
Read now
Read now
Articles from other publishers (30)
Vicente Plaza Moral, Isam Alobid, Cesáreo Álvarez Rodríguez, Marina Blanco Aparicio, Jorge Ferreira, Gabriel García, Antonio Gómez-Outes, Noé Garín Escrivá, Fernando Gómez Ruiz, Antonio Hidalgo Requena, Javier Korta Murua, Jesús Molina París, Francisco Javier Pellegrini Belinchón, Javier Plaza Zamora, Manuel Praena Crespo, Santiago Quirce Gancedo, José Sanz Ortega & José Gregorio Soto Campos. (2023) GEMA 5.3. Spanish Guideline on the Management of Asthma. Open Respiratory Archives 5:4, pages 100277.
Crossref
Crossref
Ahmad R. Alsayed, Mahmoud S. Abu-Samak & Mohammad Alkhatib. (2023) Asthma-COPD Overlap in Clinical Practice (ACO_CP 2023): Toward Precision Medicine. Journal of Personalized Medicine 13:4, pages 677.
Crossref
Crossref
Yuan Wu, Mengfen Huang, Jinyao Zhong, Yue Lu, Kao Gan, Rongyuan Yang, Yuntao Liu, Jiqiang Li & Jiankun Chen. (2023) The clinical efficacy of type 2 monoclonal antibodies in eosinophil-associated chronic airway diseases: a meta-analysis. Frontiers in Immunology 14.
Crossref
Crossref
Nicola A. Hanania & Marc Miravitlles. (2022) Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunology and Allergy Clinics of North America 42:3, pages 657-669.
Crossref
Crossref
Kasey M. Shao & Jonathan A. Bernstein. (2022) Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunology and Allergy Clinics of North America 42:3, pages 591-600.
Crossref
Crossref
Evangelia Fouka, Andriana I. Papaioannou, Georgios Hillas & Paschalis Steiropoulos. (2022) Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions. Journal of Personalized Medicine 12:5, pages 708.
Crossref
Crossref
Borja G Cosio & Hanaa Shafiek. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
702
711
.
Hikaru Toyota, Naoya Sugimoto, Konomi Kobayashi, Yuki Suzuki, Yuri Takeshita, Ayaka Ito, Mariko Ujino, Fuminori Tomyo, Hirokazu Sakasegawa, Yuta Koizumi, Michio Kuramochi, Masao Yamaguchi & Hiroyuki Nagase. (2021) Comprehensive analysis of allergen-specific IgE in COPD: mite-specific IgE specifically related to the diagnosis of asthma-COPD overlap. Allergy, Asthma & Clinical Immunology 17:1.
Crossref
Crossref
Tara Saco, Israel C. Ugalde, Juan Carlos Cardet & Thomas B. Casale. (2021) Strategies for choosing a biologic for your patient with allergy or asthma. Annals of Allergy, Asthma & Immunology 127:6, pages 627-637.
Crossref
Crossref
Meropi Karakioulaki, Eleni Papakonstantinou, Antonios Goulas & Daiana Stolz. (2021) The Role of Atopy in COPD and Asthma. Frontiers in Medicine 8.
Crossref
Crossref
Xiaofan Tu, Chantal Donovan, Richard Y. Kim, Peter A.B. Wark, Jay C. Horvat & Philip M. Hansbro. (2021) Asthma-COPD overlap: current understanding and the utility of experimental models. European Respiratory Review 30:159, pages 190185.
Crossref
Crossref
Peipei Liu, Zhongzong Pan, Chunyin Gu, Xiaodan Cao, Xiaowu Liu, Jianjian Zhang, Zheng Xiao, Xueping Wang, Haibing Guo, Dianwen Ju & Su-Jun Deng. (2020) An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases. Frontiers in Immunology 11.
Crossref
Crossref
A.N. Frix, F. Schleich, V. Paulus, F. Guissard, M. Henket & R. Louis. (2020) Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma. Biochemical Pharmacology 179, pages 113944.
Crossref
Crossref
Amlan Chakraborty & Simon G. Royce. 2020. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
97
115
.
Arzu D. Yalcin & Rusen Uzun. (2019) Anti-IgE Significantly Changes Circulating Interleukin-25, Vitamin-D and Interleukin-33 Levels in Patients with Allergic Asthma. Current Pharmaceutical Design 25:35, pages 3784-3795.
Crossref
Crossref
Diego Jose Maselli & Nicola Alexander Hanania. (2019) Management of asthma COPD overlap. Annals of Allergy, Asthma & Immunology 123:4, pages 335-344.
Crossref
Crossref
Ahmed Yousuf, Wadah Ibrahim, Neil J. Greening & Christopher E. Brightling. (2019) T2 Biologics for Chronic Obstructive Pulmonary Disease. The Journal of Allergy and Clinical Immunology: In Practice 7:5, pages 1405-1416.
Crossref
Crossref
Nicola A. Hanania, Bradley E. Chipps, Noelle M. Griffin, Bongin Yoo, Ahmar Iqbal & Thomas B. Casale. (2019) Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO. Journal of Allergy and Clinical Immunology 143:4, pages 1629-1633.e2.
Crossref
Crossref
José Carlos Herrera-García, Ek I Arellano-Montellano, Luis Enrique Jaramillo-Arellano & Andrea Espinoza- Arellano. (2019) Uso de omalizumab en cinco pacientes con síndrome de sobreposición asma-EPOC (SOAE) en un Hospital Universitario de Puebla: Un estudio observacional. NCT Neumología y Cirugía de Tórax 78:1, pages 32-36.
Crossref
Crossref
Herrera García José Carlos, Arellano Montellano Ek Ixel, Jaramillo Arellano Luis Enrique, Espinosa Arellano Andrea, Martínez Flores Alejandra Guadalupe & Caballero López Christopherson Gengyny. 2018. Asthma Diagnosis and Management - Approach Based on Phenotype and Endotype. Asthma Diagnosis and Management - Approach Based on Phenotype and Endotype.
Marco Caminati, Duy Le Pham, Diego Bagnasco & Giorgio Walter Canonica. (2018) Type 2 immunity in asthma. World Allergy Organization Journal 11, pages 13.
Crossref
Crossref
Alexandru Corlateanu, Serghei Covantev, Alexander G. Mathioudakis, Victor Botnaru & Nikolaos Siafakas. (2017) Ashtma-Chronic obstructive pulmonary disease overlap syndrome (ACOS): current evidence and future research directions. COPD Research and Practice 3:1.
Crossref
Crossref
Vicente Plaza, Francisco Álvarez, Myriam Calle, Ciro Casanova, Borja G. Cosío, Antolín López-Viña, Luís Pérez de Llano, Santiago Quirce, Miguel Román-Rodríguez, Juan José Soler-Cataluña & Marc Miravitlles. (2017) Consenso sobre el solapamiento de asma y EPOC (ACO) entre la Guía española de la EPOC (GesEPOC) y la Guía Española para el Manejo del Asma (GEMA). Archivos de Bronconeumología 53:8, pages 443-449.
Crossref
Crossref
Vicente Plaza, Francisco Álvarez, Myriam Calle, Ciro Casanova, Borja G. Cosío, Antolín López-Viña, Luís Pérez de Llano, Santiago Quirce, Miguel Román-Rodríguez, Juan José Soler-Cataluña & Marc Miravitlles. (2017) Consensus on the Asthma–COPD Overlap (ACO) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA). Archivos de Bronconeumología (English Edition) 53:8, pages 443-449.
Crossref
Crossref
. (2017) Definición, etiología, factores de riesgo y fenotipos de la EPOC. Archivos de Bronconeumología 53, pages 5-11.
Crossref
Crossref
D. Araújo, E. Padrão, M. Morais-Almeida, J. Cardoso, F. Pavão, R.B. Leite, A.C. Caldas & A. Marques. (2017) Asthma-chronic obstructive pulmonary disease overlap syndrome – Literature review and contributions towards a Portuguese consensus. Revista Portuguesa de Pneumologia (English Edition) 23:2, pages 90-99.
Crossref
Crossref
Kristin L. Hines & R. Stokes PeeblesJrJr. (2017) Management of the Asthma-COPD Overlap Syndrome (ACOS): a Review of the Evidence. Current Allergy and Asthma Reports 17:3.
Crossref
Crossref
Steven Maltby, Peter G. Gibson, Heather Powell & Vanessa M. McDonald. (2017) Omalizumab Treatment Response in a Population With Severe Allergic Asthma and Overlapping COPD. Chest 151:1, pages 78-89.
Crossref
Crossref
Yang Xia, Chao Cao, Wen Li & Huahao Shen. (2016) Severe asthma and asthma-chronic obstructive pulmonary disease syndrome. The Lancet 388:10061, pages 2741-2742.
Crossref
Crossref
B. Sposato, M. Scalese, M. Latorre, N. Scichilone, A. Matucci, M. Milanese, S. Masieri, G. Rolla, G. Steinhilber, Y. Rosati, A. Vultaggio, I. Folletti, S. Baglioni, E. Bargagli, M. Di Tomassi, R. Pio, A. Pio, U. Maccari, C. Maggiorelli, M.G. Migliorini, L. Vignale, N. Pulerà, G.E. Carpagnano, M.P. Foschino Barbaro, A. Perrella & P.L. Paggiaro. (2016) Effects of omalizumab in severe asthmatics across ages: A real life Italian experience. Respiratory Medicine 119, pages 141-149.
Crossref
Crossref